Reader Survey: Drug Discovery News hits the bullseye

Reader Survey: Drug Discovery News hits the bullseye
Register for free to listen to this article
Listen with Speechify
0:00
2:00
A readership study was recently conducted to ascertain Drug Discover News' coverage of the market and satisfaction levels of the readers. Two hundred and eighty-four respondents completed the survey, with survey results compiled and endorsed by K.C. Associates, Wilmington, Del. In the survey, readers were asked their reading habits, how well the publication covered current industry topics, and finally to rate their overall satisfaction with the publication.
Continue reading below...
A black mosquito is shown on pink human skin against a blurred green backdrop.
InfographicsDiscovering deeper insights into malaria research
Malaria continues to drive urgent research worldwide, with new therapies and tools emerging to combat the parasite’s complex lifecycle and global burden.
Read More
Readers were asked to compare the content of Drug Discovery News with other publications in the drug discovery industry and rate it "superior", "better", "average", or "below average". Seventy-nine percent of respondents replied that Drug Discovery News was either "superior" or "better" than its industry counterparts, a strong showing for a start-up publication.
Overall readership of the publication was also high. Of the 284 respondents, 47% had read all three of the last three issues, another 35% had read two with 18% reading only one issue. The reading habits also show that Drug Discovery News gains the attention of readers as soon as it hits their desk, with 79 percent of respondents saying they skim through the issue, 18 percent read it from cover to cover and only 3 percent shelve the publication for future reference.
Survey respondents were also asked to rate, on a scale of 1 to 5, with five being the best, how well DDN reported on each of the major sections of the publication, based on the mission of the publication to report on the news that impacts the drug discovery and development industry.
Continue reading below...
A white, pink, and blue 3D molecular structure of a simple sugar is shown against a light purple background.
WebinarsAdding a little sugar: what glycomics can bring to medicine
Discover how glycoscience is transforming how scientists understand diseases and opening new doors for drug discovery.
Read More
A mean rating of 3.5 to 5 would indicate the publication is meeting its goal very well, a rating from 2.5 to 3.5 is considered neutral with any rating below 2.5 indicating the publication is not meeting it's goal. In this area of overall editorial, Drug Discovery News registered a mean rating of 4.18 indicating a very strong performance in meeting the editorial goal and a very high rating for a start-up publication. Rating breakdowns for individual sections showed a similar, consistent, performance with all major sections of the newspaper receiving a mean score of 4 or higher.
In short, the reader survey showed that DDN is achieving the goal of bringing news that impacts the Drug Discovery and Development industry to its readers.

Related Topics

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Close-up of a researcher using a stylus to draw or interact with digital molecular structures on a blue scientific interface.
When molecules outgrow the limits of sketches and strings, researchers need a new way to describe and communicate them.
Portrait of Scott Weitze, Vice President of Research and Technical Standards at My Green Lab, beside text that reads “Tell us what you know: Bringing sustainability into scientific research,” with the My Green Lab logo.
Laboratories account for a surprising share of global emissions and plastic waste, making sustainability a priority for modern research.
3D illustration of RNA molecules on a gradient blue background.
With diverse emerging modalities and innovative delivery strategies, RNA therapeutics are tackling complex diseases and unmet medical needs.
Drug Discovery News September 2025 Issue
Latest IssueVolume 21 • Issue 3 • September 2025

September 2025

September 2025 Issue

Explore this issue